Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$221 |
Application for quotation of securities - SVL
|
2 Jul 2025 9:53AM |
$0.115 |
$0.120 |
risen by
4.35%
|
|
Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$221 |
Application for quotation of securities - SVL
|
2 Jul 2025 9:53AM |
$0.115 |
$0.120 |
risen by
4.35%
|
|
Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$221 |
Calico North Acquisition Completes, Kramer Earn-In Commences
|
2 Jul 2025 9:53AM |
$0.115 |
$0.120 |
risen by
4.35%
|
|
SVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Silver Mines Limited completed the acquisition of Calico North from Thomson Resources Limited.
- The Kramer Earn-In Agreement is now active, with Kramer Mining Pty Ltd able to earn up to a 70% interest in Calico North by achieving certain exploration and funding milestones.
- The acquisition strengthens Silver Mines' development and exploration portfolio in New South Wales.
- Calico North is located adjacent to Silver Mines' existing projects, providing strategic value.
- The Kramer Earn-In involves a staged process with minimum expenditure commitments and specific milestone achievements.
- Silver Mines retains a significant interest in Calico North while enabling further exploration through Kramer Mining's investment.
- The transaction and subsequent exploration are expected to generate value for shareholders and expand the company’s resource base.
- Both the acquisition and the Kramer Earn-In have been finalised as of May 29, 2024.
- Future exploration and drilling programs are planned for the Calico North Project.
- The announcement emphasizes the strategic growth and operational advancement for Silver Mines Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$6 |
Reinstatement to Quotation
|
2 Jul 2025 9:52AM |
$0.035 |
$0.020 |
fallen by
42.86%
|
|
UBI - Price-sensitive ASX Announcement
Full Release
Key Points
- Universal Biosensors, Inc. (UBI) had its securities reinstated to quotation on the ASX on 29 May 2024.
- The reinstatement followed a trading halt and voluntary suspension.
- UBI responded to ASX queries regarding its operations and disclosures.
- The company confirmed compliance with relevant listing rules and regulations.
- UBI declared that all necessary market disclosures had been made.
- Normal trading of UBI's ordinary shares resumed on the ASX from market open on 29 May 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$6 |
UBI Signs Non-Binding Term Sheet for A$8.5m Funding
|
2 Jul 2025 9:52AM |
$0.035 |
$0.020 |
fallen by
42.86%
|
|
UBI - Price-sensitive ASX Announcement
Full Release
Key Points
- UBI signed a non-binding term sheet with Mr. Richard Galanti for A$8.5 million in convertible notes funding.
- Funding will strengthen UBI's balance sheet and provide capital for growth and product development.
- Convertible notes are expected to have a three-year term and may be converted into ordinary shares.
- Completion is subject to final documentation, shareholder approval, and standard closing conditions.
- The funding supports UBI's ongoing commercialization and strategic expansion efforts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$99,978 |
NEM Announces Second Quarter 2025 Earnings Conference Call
|
2 Jul 2025 9:52AM |
$89.030 |
$90.280 |
risen by
1.40%
|
|
Harmoney Corp Limited (HMY) ORDINARY FULLY PAID |
Financials |
$59 |
Notification of cessation of securities - HMY
|
2 Jul 2025 9:51AM |
$0.565 |
$0.570 |
risen by
0.88%
|
|
QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$8 |
Final Director's Interest Notice
|
2 Jul 2025 9:51AM |
$0.036 |
$0.035 |
fallen by
2.78%
|
|
WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,622 |
Notification regarding unquoted securities - WEB
|
2 Jul 2025 9:51AM |
$4.390 |
$4.490 |
risen by
2.28%
|
|
QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$8 |
Initial Director's Interest Notice
|
2 Jul 2025 9:50AM |
$0.036 |
$0.035 |
fallen by
2.78%
|
|
Yari Minerals Limited (YAR) ORDINARY FULLY PAID |
Materials |
$7 |
Board Changes, Appendix 3X, Appendix 3Y
|
2 Jul 2025 9:50AM |
$0.013 |
$0.012 |
fallen by
7.69%
|
|
BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$2 |
R&D Agreement for Development of seaweed-based bio-stimulant
|
2 Jul 2025 9:50AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH Global Ltd has entered into an R&D agreement with Universiti Putra Malaysia (UPM).
- The agreement focuses on developing BP8, a seaweed-based bio-stimulant.
- BP8 aims to improve crop productivity through sustainable, plant-based technology.
- The collaboration leverages UPM’s scientific expertise in biotechnology and agronomy.
- Joint research activities and intellectual property management are outlined in the agreement.
- Commercialization pathways for BP8 are specified as part of the partnership.
- The initiative is aligned with BPH Global Ltd’s strategy to grow its bio-agriculture business.
- This move supports the company’s sustainability and innovation objectives.
- The agreement is expected to deliver mutual benefits to both BPH Global Ltd and UPM.
- The announcement reinforces the company’s commitment to environmentally responsible agriculture.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$8 |
QEM appoints Robert Cooper as MD and CEO
|
2 Jul 2025 9:48AM |
$0.036 |
$0.035 |
fallen by
2.78%
|
|
QEM - Price-sensitive ASX Announcement
Full Release
Key Points
- QEM Limited announced the appointment of Robert Cooper as Managing Director (MD) and Chief Executive Officer (CEO), effective immediately.
- Robert Cooper brings substantial experience in resource project development, having held senior leadership roles at several major companies, including Evolution Mining and Newcrest Mining.
- The company acknowledges Robert Cooper’s expertise in project delivery, stakeholder engagement, and operational excellence as critical assets for advancing QEM’s flagship Julia Creek vanadium and oil shale project.
- QEM Chairman John Foley expressed confidence that Cooper’s leadership will drive the next phase of growth and value creation for the company.
- The outgoing MD Gavin Loyden will remain involved in the business, continuing to support QEM’s progress as an executive director.
- QEM emphasized its focus on the development of the Julia Creek project, highlighting Cooper’s skills as pivotal in delivering key project milestones.
- The official announcement reiterates QEM’s commitment to advancing its vanadium and energy strategy, leveraging Cooper’s industry connections and experience.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Carnavale Resources Limited (CAV) ORDINARY FULLY PAID |
Materials |
$14 |
Kookynie Gold Project Grows at Swiftsure and Tiptoe
|
2 Jul 2025 9:48AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
CAV - Price-sensitive ASX Announcement
Full Release
Key Points
- Carnavale Resources Limited (CAV) updated on the Kookynie Gold Project's progress.
- Strong gold mineralisation confirmed at Swiftsure and Tiptoe prospects.
- Recent reverse circulation (RC) drilling expanded mineralised zones with significant gold intersections.
- Continuous, high-grade gold mineralisation demonstrated in multiple drill holes.
- Drilling results included notable grades over substantial thicknesses.
- Kookynie Gold Project is located in a historically productive region with accessible infrastructure.
- Exploration strategy includes ongoing drilling, targeting extensions and new zones.
- Focus on resource growth and definition through systematic exploration.
- Geological context and mineralisation controls are discussed in detail.
- Carnavale aims to unlock further value and progress towards resource estimation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Pilot Energy Limited (PGY) ORDINARY FULLY PAID |
Energy |
$19 |
Pilot places Con Notes under Discovery $1.8m Facility
|
2 Jul 2025 9:47AM |
$0.008 |
$0.009 |
risen by
12.50%
|
|
Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$12 |
Trading Halt
|
2 Jul 2025 9:47AM |
$0.017 |
$0.018 |
risen by
5.88%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited (TRU) requested a trading halt on NZX.
- The trading halt became effective on 7 June 2024.
- The halt was requested pending the release of material information to the market.
- NZX granted the trading halt to ensure market fairness and transparency.
- Trading in TRU shares will remain suspended until the announcement is released or market opens the next business day.
- Truscreen Group Limited is preparing to make a significant disclosure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Adavale Resources Limited (ADD) ORDINARY FULLY PAID |
Materials |
$71 |
Trading Halt
|
2 Jul 2025 9:47AM |
$0.032 |
$0.031 |
fallen by
3.13%
|
|
ADD - Price-sensitive ASX Announcement
Full Release
Key Points
- Adavale Resources Limited requested a trading halt on 8 July 2022.
- The reason for the trading halt is pending an announcement regarding a capital raising.
- The trading halt will last until 12 July 2022 or until the announcement is made.
- The trading halt aims to keep the market properly informed and maintain an orderly market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Adavale Resources Limited (ADD) ORDINARY FULLY PAID |
Materials |
$71 |
Pause in Trading
|
2 Jul 2025 9:46AM |
$0.032 |
$0.031 |
fallen by
3.13%
|
|
ADD - Price-sensitive ASX Announcement
Full Release
Key Points
- Adavale Resources Limited requested a trading halt on 7 June 2024.
- The halt is due to the pending release of a market-sensitive announcement.
- Trading will resume at the earlier of the announcement release or start of trading on 11 June 2024.
- The trading pause is intended to ensure a fully informed market.
- Such trading halts are standard practice for managing material disclosures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Endeavour Group Limited (EDV) ORDINARY FULLY PAID |
Consumer Staple |
$7,450 |
Notification of cessation of securities - EDV
|
2 Jul 2025 9:45AM |
$4.060 |
$4.160 |
risen by
2.46%
|
|
Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$34 |
Appointment of Jason Carroll as Non-Executive Chairman
|
2 Jul 2025 9:45AM |
$0.130 |
$0.145 |
risen by
11.54%
|
|
Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$18 |
Appendix 4G
|
2 Jul 2025 9:42AM |
$0.165 |
$0.190 |
risen by
15.15%
|
|
Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$138 |
Additional Partial Response in Pancreatic Cancer Trial
|
2 Jul 2025 9:42AM |
$0.235 |
$0.355 |
risen by
51.06%
|
|
Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$18 |
Corporate Governance Statement
|
2 Jul 2025 9:41AM |
$0.165 |
$0.190 |
risen by
15.15%
|
|
Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$18 |
Annual Report to shareholders
|
2 Jul 2025 9:40AM |
$0.165 |
$0.190 |
risen by
15.15%
|
|
SRJ Technologies Group plc (SRJ) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$2 |
Suspension from Quotation
|
2 Jul 2025 9:40AM |
$0.004 |
$0.004 |
fallen by
0%
|
|